Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer.

MLA

Furtado, Larissa V., et al. “Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer.” The Journal of Molecular Diagnostics : JMD, vol. 26, no. 8, Aug. 2024, pp. 653–68. EBSCOhost, https://doi.org/10.1016/j.jmoldx.2024.05.002.

APA

Furtado, L. V., Bifulco, C., Dolderer, D., Hsiao, S. J., Kipp, B. R., Lindeman, N. I., Ritterhouse, L. L., Temple-Smolkin, R. L., Zehir, A., & Nowak, J. A. (2024). Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer. The Journal of Molecular Diagnostics : JMD, 26(8), 653–668. https://doi.org/10.1016/j.jmoldx.2024.05.002

Chicago

Furtado, Larissa V, Carlo Bifulco, Daniel Dolderer, Susan J Hsiao, Benjamin R Kipp, Neal I Lindeman, Lauren L Ritterhouse, Robyn L Temple-Smolkin, Ahmet Zehir, and Jonathan A Nowak. 2024. “Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer.” The Journal of Molecular Diagnostics : JMD 26 (8): 653–68. doi:10.1016/j.jmoldx.2024.05.002.